American Society of Pediatric Hematology/Oncology

Last updated
American Society of Pediatric Hematology/Oncology
AbbreviationASPHO
Legal statusNon-profit
Headquarters Chicago, Illinois
Membership (2018)
2,000
President
Patrick Leavey
Immediate Past President
Amy Billett
Website aspho.org

The American Society of Pediatric Hematology/Oncology (abbreviated ASPHO) is an American multidisciplinary professional organization dedicated to improving care in the medical disciplines of pediatric hematology and oncology. [1] As of 2018, it had 2,000 members. [2]

Contents

History

The American Society of Pediatric Hematology/Oncology was founded in 1981, largely because of the efforts of physician Carl Pochedly, who served as its secretary-treasurer for fourteen years. After holding meetings jointly with the American Pediatric Society and the Society for Pediatric Research, the ASPHO held its first independent meeting in Chicago, Illinois, in 1988. [3] The society was incorporated in the state of Illinois in 1989. [2]

Publications

Since 2004, the official journal of ASPHO has been Pediatric Blood & Cancer . Its official journal was originally the Journal of Pediatric Hematology/Oncology, which was established by Pochedly in 1979 as the American Journal of Pediatric Hematology/Oncology. [2]

Related Research Articles

Pediatrics Branch of medicine that involves the medical care of infants, children, and adolescents

Paediatrics is the branch of medicine that involves the medical care of infants, children, and adolescents. The American Academy of Pediatrics recommends people seek pediatric care through the age of 21. In the United Kingdom, paediatrics covers patients until age 18. Worldwide age limits of pediatrics have been trending up year over year. A medical doctor who specializes in this area is known as a pediatrician, or paediatrician. The word pediatrics and its cognates mean "healer of children"; they derive from two Greek words: παῖς and ἰατρός. Pediatricians work in hospitals and children's hospitals particularly those working in its subspecialties, and as outpatient primary care physicians.

TAR syndrome is a rare genetic disorder that is characterized by the absence of the radius bone in the forearm and a dramatically reduced platelet count.

Chandler Park American physician

Chandler Park is an American physician, medical journalist, and clinical researcher. In June 2021, his cancer research was published in prominent medical journals including the New England Journal of Medicine and Journal of Clinical Oncology. Park also contributes regularly as an expert physician for popular newspapers and magazines such as Newsweek, Reader's Digest, U.S. News & World Report, The Exponent-Telegram, College of St. Scholastica, and Medscape and writes medical news for Doximity. In 2020, Park was selected as the President of the Kentucky Society of Clinical Oncology. The Kentucky Society of Clinical Oncology is the state affiliate of American Society of Clinical Oncology, American Society of Hematology, and National Cancer Institute.

E. Donnall Thomas American hematologist

Edward Donnall "Don" Thomas was an American physician, professor emeritus at the University of Washington, and director emeritus of the clinical research division at the Fred Hutchinson Cancer Research Center. In 1990 he shared the Nobel Prize in Physiology or Medicine with Joseph E. Murray for the development of cell and organ transplantation. Thomas and his wife and research partner Dottie Thomas developed bone marrow transplantation as a treatment for leukemia.

Alfred G. Knudson American physician and geneticist

Alfred George Knudson, Jr. was an American physician and geneticist specializing in cancer genetics. Among his many contributions to the field was the formulation of the Knudson hypothesis in 1971, which explains the effects of mutation on carcinogenesis.

Alveolar soft part sarcoma Medical condition

Alveolar soft part sarcoma, abbreviated ASPS, is a very rare type of soft-tissue sarcoma, that grows slowly and whose cell of origin is unknown.

Geriatric oncology is a branch of medicine that is concerned with the diagnosis and treatment of cancer in the elderly, usually defined as aged 65 and older. This fairly young but increasingly important subspecialty incorporates the special needs of the elderly into the treatment of cancer.

Oncology Branch of medicine dealing with cancer

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is called an Oncologist.

The European Society for Medical Oncology (ESMO) is the leading professional organisation for medical oncology. With more than 25,000 members representing oncology professionals from over 160 countries worldwide, ESMO was founded in 1975.

The Oncology Nursing Certification Corporation (ONCC) is a nonprofit organization established for the development, administration, and evaluation of programs for certification in oncology nursing. Incorporated in 1984 and governed by a board of directors, ONCC is the certifying body for oncology nursing and meets standards established by the Accreditation Board for Specialty Nursing Certification. It is accredited by the National Commission for Certifying Agencies.

Stuart Holland Orkin is an American physician, stem cell biologist and researcher in pediatric hematology-oncology. He is the David G. Nathan Distinguished Professor of Pediatrics at Harvard Medical School. Orkin's research has focused on the genetic basis of blood disorders. He is a member of the National Academy of Sciences and the Institute of Medicine, and an Investigator of the Howard Hughes Medical Institute.

Ahmed Samy Khalifa

Ahmed Samy Khalifa was an Egyptian pediatric hematologist/oncologist. He established the specialty of Pediatric Hematology/Oncology at Ain Shams University. He treated thousands of children with thalassemia, leukemia and other hematologic and ontological diseases all over Egypt.

Olga Aleinikova — is a pediatric-oncohematologist, PhD, Doctor of Medical Science (1999), Professor (2003), Corresponding Member of the National Academy of Sciences of Belarus, Director of State Institution "Belarusian Research Center for Pediatric Oncology, Hematology and Immunology".

John Bruce Beckwith is an American pediatric pathologist known for helping to identify Beckwith-Wiedemann syndrome, which is partly named after him. He is also known for his role as reference pathologist for the National Wilms Tumor Study Group, a position he held from 1969 until his retirement thirty years later. He is also recognized for his research on sudden infant death syndrome, which he helped to define in the 1960s.

Nirali N. Shah American physician-scientist and pediatric hematologist-oncologist

Nirali N. Shah is an American physician-scientist and pediatric hematologist-oncologist, serving as head of the hematologic malignancies section of the pediatric oncology branch at the National Cancer Institute. She researches the translation of immunotherapeutic approaches to treat high-risk hematologic malignancies in children, adolescents and young adults.

Andrea A. Hayes-Jordan is an American surgeon. She was the first pediatric surgeon to perform a high-risk, life-saving procedure in children with a rare form of cancer and developed the first orthotropic xenograft model of metastatic Ewing's sarcoma. In 2002, she became the first African American female pediatric surgeon board-certified in the United States.

James R. Downing is an American pediatric oncologist and executive. He is the president and chief executive officer of St. Jude Children's Research Hospital.

Michael P. Link is an American oncologist. He is the Lydia J. Lee Professor of Pediatric Hematology/Oncology at Stanford University School of Medicine.

Richard B. Gaynor is an American physician specializing in hematology-oncology, educator, drug developer, and business executive. He served as an Associate Professor of Medicine at UCLA School of Medicine for nearly a decade, and subsequently as an endowed Professor of Medicine and Microbiology at the University of Texas Southwestern Medical School prior to joining the pharmaceutical industry in 2002. His research on NF-κB, IκB kinase, and other mechanisms regulating viral and cellular gene expression has been covered in leading subject reviews. He has been a top executive at several pharmaceutical companies, with respect to the development and clinical testing of novel anticancer drugs and cell therapies. For over a decade and a half, he worked at Eli Lilly and Company, where he became the Senior Vice President of Oncology Clinical Development and Medical Affairs in 2013. Gaynor was President of R&D at Neon Therapeutics from 2016 to 2020, when he became the President of BioNTech US, both pharmaceutical companies headquartered in Cambridge, MA.

Roland B. Scott

Roland Boyd Scott was an American sickle cell researcher and pediatrician. He is frequently cited as an authority on sickle cell disease. Scott authored a key paper in 1948 describing the incidence of sickle cell in infants that eventually led to the establishment of routine screening for newborns. He established the Howard University Center for Sickle Cell Disease. He was chairman of the pediatrics department at Howard University. He lobbied Congress to pass the Sickle Cell Anemia Control Act of 1971. He authored over 250 academic publications on allergy, growth and development, and sickle cell disease.

References

  1. Seibel N (November 2006). "The American Society of Pediatric Hematology/Oncology". Journal of Oncology Practice. 2 (6): 313. doi:10.1200/jop.2006.2.6.313. PMC   2793658 . PMID   29447566.
  2. 1 2 3 "About". aspho.org. Retrieved 2018-08-24.
  3. Pearson HA (December 2002). "History of pediatric hematology oncology". Pediatric Research. 52 (6): 979–92. doi: 10.1203/00006450-200212000-00026 . PMID   12438679.